This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medical Corporation Ichikawa Clinic. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations by Yoshifusa Kondo
Introduction
Yoshifusa Kondo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in developing methods for producing compositions with cytocidal activity. His work is characterized by a focus on innovative techniques that can potentially impact cancer treatment.
Latest Patents
Yoshifusa Kondo holds 2 patents. His latest patents include a method for preparing a cell extract component or composition that exhibits cytocidal activity. This method involves culturing malignant tumor-derived cells in a culture medium until the cell density reaches a suitable level for transfer. After culturing, the culture medium is replaced with a physiological buffer salt solution. The physiological buffer salt solution is then recovered after the morphological death of the malignant tumor-derived cells is observed.
Career Highlights
Kondo is associated with the Medical Corporation Ichikawa Clinic, where he applies his expertise in medical innovations. His work at the clinic emphasizes the importance of research and development in the medical field, particularly in cancer therapies.
Collaborations
Yoshifusa Kondo collaborates with Tomoyuki Tajima, contributing to advancements in their shared field of medical research.
Conclusion
Yoshifusa Kondo's innovative methods and dedication to medical research highlight his role as a significant inventor in the field. His contributions may pave the way for new treatments in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile